FRESENIUS MEDICAL CARE-ADR (FMS) Fundamental Analysis & Valuation
NYSE:FMS • US3580291066
Current stock price
22.49 USD
-0.67 (-2.89%)
Last:
This FMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. FMS Profitability Analysis
1.1 Basic Checks
- FMS had positive earnings in the past year.
- In the past year FMS had a positive cash flow from operations.
- In the past 5 years FMS has always been profitable.
- In the past 5 years FMS always reported a positive cash flow from operatings.
1.2 Ratios
- FMS's Return On Assets of 3.16% is fine compared to the rest of the industry. FMS outperforms 66.34% of its industry peers.
- FMS's Return On Equity of 7.35% is fine compared to the rest of the industry. FMS outperforms 65.35% of its industry peers.
- FMS has a Return On Invested Capital (5.30%) which is comparable to the rest of the industry.
- The Average Return On Invested Capital over the past 3 years for FMS is below the industry average of 8.92%.
- The 3 year average ROIC (4.02%) for FMS is below the current ROIC(5.30%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| ROIC | 5.3% |
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
1.3 Margins
- FMS has a Profit Margin of 4.98%. This is in the better half of the industry: FMS outperforms 79.21% of its industry peers.
- FMS's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 9.00%, FMS is in the better half of the industry, outperforming 77.23% of the companies in the same industry.
- FMS's Operating Margin has declined in the last couple of years.
- FMS has a Gross Margin (25.62%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of FMS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9% | ||
| PM (TTM) | 4.98% | ||
| GM | 25.62% |
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
2. FMS Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FMS is still creating some value.
- Compared to 1 year ago, FMS has less shares outstanding
- Compared to 5 years ago, FMS has less shares outstanding
- Compared to 1 year ago, FMS has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 1.84 indicates that FMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
- FMS has a Altman-Z score (1.84) which is comparable to the rest of the industry.
- The Debt to FCF ratio of FMS is 6.19, which is on the high side as it means it would take FMS, 6.19 years of fcf income to pay off all of its debts.
- FMS has a Debt to FCF ratio of 6.19. This is comparable to the rest of the industry: FMS outperforms 55.45% of its industry peers.
- FMS has a Debt/Equity ratio of 0.65. This is a neutral value indicating FMS is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.65, FMS perfoms like the industry average, outperforming 56.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.19 | ||
| Altman-Z | 1.84 |
ROIC/WACC1.01
WACC5.23%
2.3 Liquidity
- A Current Ratio of 1.26 indicates that FMS should not have too much problems paying its short term obligations.
- FMS's Current ratio of 1.26 is in line compared to the rest of the industry. FMS outperforms 48.51% of its industry peers.
- FMS has a Quick Ratio of 1.26. This is a bad value and indicates that FMS is not financially healthy enough and could expect problems in meeting its short term obligations.
- FMS's Quick ratio of 0.92 is on the low side compared to the rest of the industry. FMS is outperformed by 71.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.92 |
3. FMS Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 32.00% over the past year.
- Measured over the past years, FMS shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.51% on average per year.
- The Revenue has been growing slightly by 1.51% in the past year.
- FMS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.91% yearly.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
3.2 Future
- FMS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.03% yearly.
- FMS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.69% yearly.
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. FMS Valuation Analysis
4.1 Price/Earnings Ratio
- FMS is valuated reasonably with a Price/Earnings ratio of 9.33.
- Based on the Price/Earnings ratio, FMS is valued cheaply inside the industry as 94.06% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of FMS to the average of the S&P500 Index (26.11), we can say FMS is valued rather cheaply.
- With a Price/Forward Earnings ratio of 9.99, the valuation of FMS can be described as very reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 90.10% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of FMS to the average of the S&P500 Index (24.12), we can say FMS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.33 | ||
| Fwd PE | 9.99 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 90.10% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, FMS is valued cheaply inside the industry as 89.11% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.56 | ||
| EV/EBITDA | 6.15 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.07%
EPS Next 3Y6.69%
5. FMS Dividend Analysis
5.1 Amount
- FMS has a Yearly Dividend Yield of 3.62%. Purely for dividend investing, there may be better candidates out there.
- FMS's Dividend Yield is rather good when compared to the industry average which is at 0.50. FMS pays more dividend than 98.02% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.91, FMS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.62% |
5.2 History
- The dividend of FMS has a limited annual growth rate of 4.43%.
- FMS has paid a dividend for at least 10 years, which is a reliable track record.
- The dividend of FMS decreased in the last 3 years.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- FMS pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
- FMS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP43.19%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
FMS Fundamentals: All Metrics, Ratios and Statistics
NYSE:FMS (3/18/2026, 11:15:33 AM)
22.49
-0.67 (-2.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24 2026-02-24/dmh
Earnings (Next)05-05 2026-05-05
Inst Owners44.27%
Inst Owner Change6.19%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.20B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target27.2 (20.94%)
Short Float %0.5%
Short Ratio3.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.62% |
Yearly Dividend0.82
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)0.14%
PT rev (3m)-2.47%
EPS NQ rev (1m)27.66%
EPS NQ rev (3m)91.48%
EPS NY rev (1m)-5.37%
EPS NY rev (3m)-5.24%
Revenue NQ rev (1m)-5.25%
Revenue NQ rev (3m)-4.55%
Revenue NY rev (1m)-2.09%
Revenue NY rev (3m)-2.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.33 | ||
| Fwd PE | 9.99 | ||
| P/S | 0.58 | ||
| P/FCF | 6.56 | ||
| P/OCF | 4.27 | ||
| P/B | 0.86 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.15 |
EPS(TTM)2.41
EY10.72%
EPS(NY)2.25
Fwd EY10.01%
FCF(TTM)3.43
FCFY15.23%
OCF(TTM)5.27
OCFY23.42%
SpS38.57
BVpS26.15
TBVpS-2.98
PEG (NY)N/A
PEG (5Y)N/A
Graham Number37.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| ROCE | 7.13% | ||
| ROIC | 5.3% | ||
| ROICexc | 5.78% | ||
| ROICexgc | 16.63% | ||
| OM | 9% | ||
| PM (TTM) | 4.98% | ||
| GM | 25.62% | ||
| FCFM | 8.88% |
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.19 | ||
| Debt/EBITDA | 2.64 | ||
| Cap/Depr | 62.47% | ||
| Cap/Sales | 4.78% | ||
| Interest Coverage | 4.9 | ||
| Cash Conversion | 82.09% | ||
| Profit Quality | 178.22% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.84 |
F-Score8
WACC5.23%
ROIC/WACC1.01
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year72.47%
EBIT Next 3Y24.27%
EBIT Next 5Y15.34%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%
FRESENIUS MEDICAL CARE-ADR / FMS Fundamental Analysis FAQ
What is the fundamental rating for FMS stock?
ChartMill assigns a fundamental rating of 5 / 10 to FMS.
Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.
What is the profitability of FMS stock?
FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.
What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?
The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to decline by -6.53% in the next year.
Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?
The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 43.19%.